Clinical Use of Phosphodiesterase-5 Inhibitors in Chronic Heart Failure

被引：38
作者：
Guazzi, Marco [1 ]
机构：
[1] Univ Milan, Heart Failure Unit, Cardiopulm Lab, San Paolo Hosp,Dept Med & Surg, I-20142 Milan, Italy
来源：
CIRCULATION-HEART FAILURE | 2008年 / 1卷 / 04期
关键词：
heart failure; pharmacology;
D O I：
10.1161/CIRCHEARTFAILURE.108.802116
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：272 / 280
页数：9
相关论文
共 71 条
  • [1] The effects of intravenous sildenafil on hemodynamics and cardiac sympathetic activity in chronic human heart failure
    Al-Hesayen, Abdul
    Floras, John S.
    Parker, John D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (08) : 864 - 868
  • [2] Development of a ventilatory classification system in patients with heart failure
    Arena, Ross
    Myers, Jonathan
    Abella, Joshua
    Peberdy, Mary Ann
    Bensimhon, Daniel
    Chase, Paul
    Guazzi, Marco
    [J]. CIRCULATION, 2007, 115 (18) : 2410 - 2417
  • [3] Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes
    Ballard, SA
    Gingell, CJ
    Tang, K
    Turner, LA
    Price, ME
    Naylor, AM
    [J]. JOURNAL OF UROLOGY, 1998, 159 (06) : 2164 - 2171
  • [4] Effects of 5′-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure:: A double-blind, placebo-controlled clinical trial
    Behling, Alice
    Rohde, Luis E.
    Colombo, Fernanda C.
    Goldraich, Livia A.
    Stein, Ricardo
    Clausell, Nadine
    [J]. JOURNAL OF CARDIAC FAILURE, 2008, 14 (03) : 189 - 197
  • [5] Sildenaril effects on exercise, neurohormonal activation, and erectile dysfunction in congestive heart failure - A double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction
    Bocchi, EA
    Guimaraes, G
    Mocelin, A
    Bacal, F
    Bellotti, G
    Ramires, JF
    [J]. CIRCULATION, 2002, 106 (09) : 1097 - 1103
  • [6] Boolell M, 1996, Int J Impot Res, V8, P47
  • [7] Sildenafil inhibits β-adrenergic-stimulated cardiac contractility in humans
    Borlaug, BA
    Melenovsky, V
    Marhin, T
    Fitzgerald, P
    Kass, DA
    [J]. CIRCULATION, 2005, 112 (17) : 2642 - 2649
  • [8] Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED
    Boyle, CD
    Xu, R
    Asberom, T
    Chackalamannil, S
    Clader, JW
    Greenlee, WJ
    Guzik, H
    Hu, YQ
    Hu, ZY
    Lankin, CM
    Pissarnitski, DA
    Stamford, AW
    Wang, YG
    Skell, J
    Kurowski, S
    Vemulapalli, S
    Palamanda, J
    Chintala, M
    Wu, P
    Myers, J
    Wang, P
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (09) : 2365 - 2369
  • [9] A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)
    Califf, RM
    Adams, KF
    McKenna, WJ
    Gheorghiade, M
    Uretsky, BF
    McNulty, SE
    Darius, H
    Schulman, K
    Zannad, F
    HandbergThurmond, E
    Harrell, FE
    Wheeler, W
    SolerSoler, J
    Swedberg, K
    [J]. AMERICAN HEART JOURNAL, 1997, 134 (01) : 44 - 54
  • [10] Effect of PDE5 inhibition on coronary hemodynamics in pacing-induced heart failure
    Chen, YJ
    Traverse, JH
    Hou, MX
    Li, YF
    Du, RS
    Bache, RJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 284 (05): : H1513 - H1520
12345678